Aligos Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-46.8M | $-49.6M | $2.8M | $752.0K |
| FY2020 | $-74.3M | $-76.3M | $2.1M | $3.0M |
| FY2021 | $-115.7M | $-116.6M | $892.0K | $13.5M |
| FY2022 | $-79.4M | $-80.3M | $943.0K | $14.7M |
| FY2023 | $-79.0M | $-79.0M | $19.0K | $12.7M |
| FY2024 | $-80.7M | $-80.9M | $130.0K | $8.5M |
| FY2025 | $-82.5M | $-82.5M | — | $5.0M |